Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study aims to decode cancer fatigue language for better care

NCT ID NCT06634381

First seen Feb 02, 2026 · Last updated Jun 22, 2026 · Updated 17 times

Summary

This study interviews 80 cancer survivors and their doctors to understand how they describe cancer-related fatigue. The goal is to create a visual aid (like a Venn diagram) that helps patients and providers communicate more effectively about this common symptom. The study does not test any drug or treatment, but aims to improve understanding and management of fatigue.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Levine Cancer Institute

    RECRUITING

    Charlotte, North Carolina, 28204, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Levine Childrens Hospital Pediatric Cancer and Blood Disorders

    RECRUITING

    Charlotte, North Carolina, 28203, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Wake Forest Baptist Comprehensive Cancer Center

    RECRUITING

    Winston-Salem, North Carolina, 27157, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a simple visual tool that helps cancer survivors and doctors talk about fatigue more clearly, potentially improving symptom management.

What could go wrong

This is a small, early-stage pilot study (80 participants) that only collects descriptions and creates a visual aid. It does not test any treatment, so it may not directly improve fatigue or lead to a proven solution.

Conditions

The condition(s) this trial relates to.

cancer Fatigue neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.